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Case Report 
IgG4-Related Laryngeal Disease as a Possible Cause of Idiopathic 
Subglottic Stenosis: A Case Report 
Ádám Bach1, (Ph.D), Andrea Ambrus1, (MD); Béla Iványi2, (Ph.D); Zoltán Tóbiás1, (MD);  
*Gholam Hossein Alim Marvasti1, (MD); László Rovó1, (Ph.D)  
Abstract 
Introduction: 
Immunoglobulin G4-related disease (IgG4-RD) is a systemic fibro-inflammatory disorder.  
Laryngotracheal manifestation is very rare; therefore, it is usually associated with complex diagnostic 
and therapeutic problems.  
 
Case Report:  
Herein, we report the case of a 35-year-old woman with idiopathic subglottic stenosis (ISGS) treated 
with one-step laryngotracheal reconstruction surgery. Postoperatively, the lesion was found to be a part 
of the IgG4-RD spectrum. Objective and subjective phoniatric tests, spirometry, and Quality of Life 
Questionnaire were used for the evaluation of postoperative functional results. Slide 
laryngotracheoplasty as a one-step surgery without stenting and tracheostomy ensured a sufficiently 
wide subglottic space with no adverse effect on voice quality. During a follow-up period of 22 months, 
endoscopy and computed tomography scan revealed no significant restenosis. The patient was able to 
return to premorbid activities of daily living without any further medical treatment.  
Conclusion:  
The laryngeal involvement of IgG4-RD is uncommon; however, it is a manifestation that should be 
included in the differential diagnosis of subglottic stenoses (SGS). Furthermore, subglottic IgG4-RD 
might be a potential etiological factor of ISGS and acquired airway stenosis after short-term intubation. 
Slide laryngotracheoplasty might be a favorable solution without stenting and tracheostomy even in 
special cases of SGS. 
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Introduction 
Immunoglobulin G4-related disease (IgG4-
RD) is a rare immune-mediated fibro-
inflammatory disorder of unknown origin with 
heterogeneous pathologic features and variable 
disease manifestations. IgG4-RD is a systematic 
condition characterized by abundant IgG4 
positive plasma cell infiltration and tumor-like 
lesions of the involved organs and consequently 
is often misdiagnosed as either malignancy or 
granulomatous conditions (1-4). Single organ 
manifestations have already been described 
more than 125 years ago; nonetheless, a 
consensus on description and nomenclature was 
achieved only in the last decade (5). 
Autoimmune pancreatitis represents the 
prototype of IgG4-RD; however, IgG4-RD may 
affect virtually any organ (2). The interest in 
IgG4-RD has considerably grown in the past few 
years and extended to specific disorders across 
most medical subspecialties. A broader 
understanding of IgG4-RD has led to the 
recognition that many medical conditions long 
viewed as unique diseases are part of the IgG4-
RD spectrum. The expanding list of organs 
involved in IgG4-RD includes the pancreas 
(autoimmune pancreatitis), biliary ducts 
(sclerosing cholangitis), kidneys 
(tubuleinterstitial nephritis), meninges, aorta, 
lungs, prostate, breast, pericardium, pituitary 
gland, lymph nodes, and skin (1,4,6). The head 
and neck region, especially the orbits (chronic 
sclerosing dacryoadenitis and inflammatory 
orbital pseudotumor), paranasal sinuses, major 
salivary glands (Küttner’s tumor), and thyroid 
gland (Riedel’s thyroiditis) are among the most 
frequent areas of involvement (3). Nevertheless, 
the laryngotracheal manifestation is very rare; 
therefore, it is usually associated with complex 
diagnostic problems. Herein, we report a patient 
with idiopathic subglottic stenosis (ISGS) 
treated with one-step laryngotracheal 
reconstruction surgery. Postoperatively, the 
lesion was found to be a part of the IgG4-RD 
spectrum. This case emphasizes the necessity to 
contemplate IgG4-RD in the differential 
diagnosis of ISGS and simultaneously 




A 35-year-old Caucasian woman presented 
with an 8-year history of progressive dyspnea 
on exertion. She had no history of prolonged 
intubation, airway trauma, or gastroesophageal 
reflux disease (GERD) and was a lifetime non-
smoker. Apart from insulin-dependent diabetes 
mellitus, she had no other chronic disease.  
The breathing problem started after a 
septorhinoplasty under general anesthesia, 
performed due to a spontaneous deformation of 
the cartilaginous nasal septum. To identify a 
supposed underlying autoimmune disease, 
blood tests and histopathologic examinations 
were performed. Autoimmune panel [Anti–
Sjögren syndrome A antibody (SS-A); Anti–
Sjögren syndrome B antibody (SS-B); 
antinuclear antibody (ANA); anti-neutrophil 
cytoplasmic antibody (ANCA); anti-
topoisomerase I antibody (Scl-70); anti-histidil-
tRNA synthetase antibody (Jo-1); anti-
Smith/Ribonucleoprotein antibody (Sm/RNP); 
anti-Centromer-B antibody; anti-
myeloperoxidase antibody (MPO); anti-
proteinase-3 antibody (PR3)] showed negative 
result, and the histopathology findings of the 
nasal cartilage and mucosa were normal. In the 
next 8 years, no symptoms occurred other than 
dyspnea with slow progression. Finally, a 
computed tomography scan revealed an 
approximately 10 mm long, subglottic, 
circumferential soft-tissue mass with a lumen 
diameter of 4 mm (Fig.1a). No clinical or 
radiological evidence of the disease was 
observed outside the larynx. Direct 
laryngotracheoscopy under general anesthesia 
with jet ventilation revealed a circumferential 
fibrotic subglottic stenosis (SGS) (Fig.1b). No 
other airway abnormality was identified by the 
endoscopic examination. The patient 
underwent a slide laryngotracheoplasty as 
described in an earlier publication (7). Partial 
midline anterior laryngofissure was performed 
after the exploration of the laryngotracheal 
complex and careful dissection of the 
cricotracheal junction. The cricoid and thyroid 
cartilage was divided in the midline until the 
level of the anterior commissure (Fig's 2a and 
2b). Then, the plate of the cricoid cartilage was 
incised in the midline. Increased attention was 
paid to the preservation of the posterior 
perichondrium, posterior cricoarytenoid, and 
pharyngeal constrictor muscle integrity.  
Laryngeal release and mobilization of the distal 
trachea were also performed. Accordingly, the 
anterior cartilage rings of the trachea could be 
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easily pulled up to the level of the anterior 
commissure. The posterior membranous part of 
the trachea was sufficiently cropped in order to 
perfectly fit the posterior subglottic mucosa 
(Fig.2b).  
Finally, an anastomosis was created between 
the trachea, anterior cricoid, and midline 
incised thyroid cartilage with double-armed 
continuous locked sutures (Fig's 2c, 2d, 2e, 
and 2f). 
 
Fig 1: a) three-dimensional computed tomography 
reconstruction of the air shadow (preoperative). 1: glottic 
level; 2: subglottic stenosis; R: right main bronchus; L: 
left main bronchus. b) direct preoperative endoscopic 
picture of the stenotic airway; the subglottic airway 
covered by a metaplastic exfoliative squamous 
epithelium.c) direct endoscopic picture of the larynx 
during inspiration (22nd postoperative month) 
 
Fig 2: a) partial anterior laryngofissure; 1: incised 
thyroid cartilage; 2: cricoid cartilage; *: 
endotracheal tube. b) partial anterior laryngofissure 
with the preservation of the anterior commissure of 
the vocal folds; partial resection of membranous part 
of the trachea. c) reconstruction of the posterior 
wall; 1: thyroid cartilage; 2: cricoid cartilage; 3: 
anastomosis of the posterior wall. d) formation of an 
anastomosis between the trachea, cricoid, and 
thyroid; firstly, reconstruction of the posterior wall. 
e) reconstruction of the anterior wall; 1: thyroid 
cartilage; 2: second tracheal ring. f) reconstructed 
anterior and lateral wall 
 
Histologic findings revealed the replacement 
of the respiratory epithelium by metaplastic 
non-dysplastic squamous epithelium. The 
submucosa was thickened by dense 
lymphoplasmacytic infiltrates and focally 
storiform fibrosis. The plasma cell infiltrates 
proved to be polyclonal, with the abundance of 
IgG4-positive plasma cells. The ratio of IgG4-
positive plasma cells per IgG-positive plasma 
cell was 75%. Obliterative phlebitis, tissue 
eosinophilia, or granulomas were not detected 
(Fig.3). 
 
Fig 3: Trichrome-stained tissue section at low-
power micrograph: the submucosa (S) thickened by 
small round cell infiltrates and collagen deposition 
(blue); the respiratory epithelium replaced by 
metaplastic squamous epithelium (E). 
Hematoxylin-eosin (HE)-stained tissue section at 
low-power micrograph: storiform pattern of fibrosis 
and dense infiltrates rich in plasma cells in the deep 
submucosa; (C): tracheal cartilage  
Immunoglobulin G4-related disease (IgG4)-stained 
tissue sections: at low power magnification, 
abundant number of IgG4-positive plasma cells 
under the squamous epithelium (E); a great number 
of IgG4-positive plasma cells in the deep 
submucosa; C: tracheal cartilage.  
No major perioperative or postoperative 
complications occurred. The patient was 
discharged on the 9th postoperative day with 
good swallowing and breathing. The 
postoperative ultrasound did not show any 
fibro-inflammatory disorder in the thyroid and 
salivary glands. The serum IgG4 level of the 
patient was 366 mg/l one week after the 
surgery. In addition, 6 weeks after the 
intervention, the patient was able to return to 
her premorbid way of life. During the follow-
up period of 22 months, endoscopy revealed no 
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significant restenosis (Figure 1c). The serum 
IgG4 level did not significantly change (317 
mg/l in the 16th postoperative month).  
The peak inspiratory flow increased from 2.3 
to 3.8 L/sec (change: 1.54 L/sec; 167% of the 
baseline) (8). The improvement of the quality-
of-life score by 53% (from 15 to 7) also showed 
the patient’s satisfaction with her respiratory 
function (9). All the objective voice parameters 
were within the physiological range in the 22nd 
postoperative month: Fundamental frequency: 
250.1 Hz; Jitter%: 0.33; Shimmer%: 2.82; 
Harmonics-to-Noise Ratio: 26.2 dB; Maximum 
Phonation Time: 19.6 s (10). The Voice 
Handicap Index demonstrated that the patient’s 
voice also improved (decreased from 20 to 2; 
10% of baseline) (11).  
 
Discussion 
Approximately, 5% of all acquired SGS 
considered idiopathic after all possible causes 
(i.e., trauma from intubation, surgery, radiation, 
autoimmune disorders, infectious processes, 
and congenital abnormalities) have been ruled 
out (12). The true etiologies of ISGS have been 
disputed for decades; nevertheless, it still 
remains unclear. The pathogenic process is 
most likely multifactorial. Estrogen and GERD 
have been theorized to play a role in the 
development of ISGS (13-15). In addition, a 
subgroup of ISGS patients may suffer from 
limited granulomatosis with polyangiitis 
(Wegener’s granulomatosis). However, the 
biopsies of airway lesions lack the typical 
histologic findings and diagnostic serologic 
markers (16,17). Based on the presented case, 
IgG4-RD should be kept in mind in case of 
ISGS. The IgG4-RD can involve virtually any 
organ or tissue. Therefore, the clinical 
presentation is very heterogeneous. Some 
patients present with a single site involved and 
others may have a few or many organs affected 
by IgG4-RD. These may develop 
simultaneously or sequentially. On the other 
hand, several other diseases (e.g., infections, 
autoimmune diseases, and cancers) can be 
associated with the increased levels of IgG4 
(4,18,19). Histopathology is a hallmark in the 
diagnosis of IgG4-RD, with diffuse 
lymphoplasmacytic infiltrate with an 
abundance of IgG4-positive plasma cells, 
storiform fibrosis, with or without obliterative 
phlebitis and eosinophilia (3,20). An IgG4/IgG 
tissue plasma cell ratio higher than 40% 
strongly suggests the disease. Meanwhile, the 
presence of neutrophils, neutrophilic 
microabscesses, granulomas, and necrotizing 
vasculitis does not support the diagnosis of 
IgG4-RD (21). Elevated serum IgG4 
concentration is not necessary for the diagnosis 
(22). Approximately, 30% of patients with 
biopsy-proven IgG4-RD have normal serum 
IgG4 concentrations (1,23,24).  
The IgG4 antibody has a low antigen-binding 
affinity and accounts for less than 5% of total 
IgG concentration, with IgG4 concentrations 
within the range of 0.01-1.4 mg/dL and 
variability of 5-50x among healthy individuals 
(24). Important details remain unknown about 
IgG4-RD, including the pathophysiologic 
mechanism, exact role of IgG4, and individual 
organ manifestation. However, head and neck 
manifestations are quite common, laryngeal 
involvement was described only in a limited 
number of cases (3).  
Völker et al. described the first laryngeal 
manifestation of IgG4-RD in 2009. Since then, 
isolated subglottic involvement and tracheal 
and hypopharyngo-laryngeal involvements 
have been reported (23, 25-30) (Table.1).  
 




year gender/age (year) 
Völker et al. 2009 Male/56 Left false cord Laser resection and corticosteroid 
Virk et al. 2012 Female/22 Subglottic stenosis 
Laser resection, dilatation, prednisolone, and 
laryngotracheal reconstruction with costal cartilage graft 
Khoo et al. 2013 Male/62 Supraglottic Prednisolone 
Shaib et al. 2013 
Male/56 Right anterior subglottic area Laser resection and tracheotomy 
Male/57 Mucosal hyperplasia of pharynx and larynx Prednisolone 
Kobraei et al. 2013 Female/26 Distal trachea mass Excision, laser debridement, and tracheal resection 
Reder et al. 2014 
Male/58 
Base of tongue, left aryepiglottic fold, 
Laser resection, prednisolone, methylprednisolone, and rituximab 
right vocal process, and left piriform sinus 
Male/62 
Base of tongue, epiglottis, aryepiglottic folds, 
Prednisolone, methylprednisolone, and rituximab 
and false and true vocal folds 
Hamadini 2017 Female/54 Postcricoid ulcer not reported 
 
Igg4-Related Laryngeal Disease 
Iranian Journal of Otorhinolaryngology, Vol.33(2), Serial No.115, Mar 2021  123 
It is assumed that due to the local IgG4-RD 
presentation, even short-term intubation was 
enough for the initiation of the mucosal 
inflammation process and fibrotic remodeling 
of the airway mucosa. This might be the way 
how the former asymptomatic low-grade 
stenosis became manifest. The typical 
tumefactive appearance of the lesion remained 
hidden by the metaplastic non-dysplastic 
squamous epithelium, caused by the 
mechanical injury by the endotracheal tube 
(31). The early diagnosis and effective 
management of IgG4-RD are crucial for the 
prevention of sclerotic changes, irreversible 
organ disfunction, unnecessary medication 
therapy, and surgical procedures. The treatment 
heterogeneity in the few reported cases of 
IgG4-RD with airway involvement is 
conspicuous. There is no evidence-based 
treatment protocol from randomized controlled 
trials. According to the clinical experience, 
most IgG4-RD patients favorably respond to 
glucocorticoid (GC) treatment (4,27,28). Reder 
et al. described the effectivity of anti-CD20 
monoclonal antibody rituximab in patients with 
hypopharyngo-laryngeal involvement (23). 
The use of other more intense drugs, such as 
bortezomib, fludarabine, and 
cyclophosphamide, which are efficient in 
patients with other organ involvement, has not 
yet been investigated in airway patients  
(31-34). In previously published cases with 
glottic-subglottic and/or tracheal involvement, 
GC as a monotherapy (prednisolone and/or 
methylprednisolone) was not effective (25,27, 
28,30,31). Long-standing fibrotic lesions of 
IgG4-RD generally do not respond well to 
conservative treatment and surgical resection 
may be preferred (24).  
In addition, the surgical solution should be 
primarily chosen in cases of lesions involving 
critical airway stenosis (29). In case of slide 
laryngotracheoplasty, a vascularized local 
trachea flap is used for the augmentation of the 
subglottic airway. The technique provides an 
appropriate subglottic airway without graft 
absorption and donor site reaction. The entire 
cricoid ring, recurrent nerves, and cricothyroid 
muscles are preserved, which contribute to the 
good functional outcomes. 
Relapse may develop in the originally affected 
organs; however, it can also occur in 
completely different sites. Furthermore, there is 
no consensus on the systematic follow-up of 
IgG4-RD patients, and it is still not clear 
whether IgG4 level can be used for the 
assessment of treatment response (35). Despite 
the partial removal of the stenotic lesion and 
lack of GC therapy, no recurrence was observed 
during the follow-up in the presented case. 
Spontaneous remission of IgG4-RD is not 
unknown; nevertheless, further investigation is 
required to clarify the triggering and reducing 




The laryngeal involvement of IgG4-RD is 
uncommon; nonetheless, it is a manifestation 
that should be included in the differential 
diagnosis of SGS. Furthermore, subglottic 
IgG4-RD might be a potential etiological factor 
of ISGS and acquired airway stenosis after 
short-term intubation. Herein, we presented an 
easily performed reconstruction option using 
readily available vascularized local tissues. 
Slide laryngotracheoplasty might be a favorable 
solution without stenting and tracheostomy 
even in special cases of SGS. 
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